Synapsin III: Role in neuronal plasticity and disease

Seminars in Cell and Developmental Biology

Volumn 22, Issue 4, 2011, Pages 416-424

  Porton, Barbara ^a,b   Wetsel, William C ^c   Kao, Hung Teh ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Axon formation; Dopamine; Neurogenesis; Phosphoprotein; Polymorphism; Schizophrenia

Indexed keywords

DOPAMINE; SYNAPSIN; SYNAPSIN I; SYNAPSIN II; SYNAPSIN III; UNCLASSIFIED DRUG;

ATTENTION; AUTOPSY; BIPOLAR DISORDER; BRAIN DISEASE; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHROMOSOME 22Q; COGNITIVE DEFECT; CORPUS STRIATUM; DENTATE GYRUS; DOPAMINE RELEASE; EXECUTIVE FUNCTION; GABAERGIC TRANSMISSION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRON; MEMORY DISORDER; MENTAL DISEASE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SEIZURE; SEMANTIC MEMORY; SENSORY GATING; SPATIAL MEMORY; SYNAPSE VESICLE; VISUAL MEMORY; WORKING MEMORY;

EID: 80052726517     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.07.007     Document Type: Review

References (127)

1. Greengard P., Valtorta F., Czernik A.J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259:780-785.
2. Kao H.T., Porton B., Hilfiker S., Stefani G., Pieribone V.A., DeSalle R., et al. Molecular evolution of the synapsin gene family. J Exp Zool 1999, 285:360-377.
3. Forn J., Greengard P. Depolarizing agents and cyclic nucleotides regulate the phosphorylation of specific neuronal proteins in rat cerebral cortex slices. Proc Natl Acad Sci USA 1978, 75:5195-5199.
4. Ueda T., Greengard P. Adenosine 3':5'-monophosphate-regulated phosphoprotein system of neuronal membranes, I. Solubilization, purification, and some properties of an endogenous phosphoprotein. J Biol Chem 1977, 252:5155-5163.
5. 2+. J Biol Chem 1998, 273:13371-13374.
6. Kao H.T., Porton B., Czernik A.J., Feng J., Yiu G., Haring M., et al. A third member of the synapsin gene family. Proc Natl Acad Sci USA 1998, 95:4667-4672.
7. Porton B., Ferreira A., DeLisi L.E., Kao H.T. A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia. Biol Psychiatry 2004, 55:118-125.
8. Porton B., Kao H.T., Greengard P. Characterization of transcripts from the synapsin III gene locus. J Neurochem 1999, 73:2266-2271.
9. Esser L., Wang C.R., Hosaka M., Smagula C.S., Sudhof T.C., Deisenhofer J. Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J 1998, 17:977-984.
10. 2+ regulation. J Biol Chem 1998, 273:1425-1429.
11. Ferreira A., Kao H.T., Feng J., Rapoport M., Greengard P. Synapsin III: developmental expression, subcellular localization, and role in axon formation. J Neurosci 2000, 20:3736-3744.
12. Hosaka M., Sudhof T.C. Homo- and heterodimerization of synapsins. J Biol Chem 1999, 274:16747-16753.
13. Greengard P., Browning M.D., McGuinness T.L., Llinas R. Synapsin I, a phosphoprotein associated with synaptic vesicles: possible role in regulation of neurotransmitter release. Adv Exp Med Biol 1987, 221:135-153.
14. Feng J., Chi P., Blanpied T.A., Xu Y., Magarinos A.M., Ferreira A., et al. Regulation of neurotransmitter release by synapsin III. J Neurosci 2002, 22:4372-4380.
15. Rosahl T.W., Spillane D., Missler M., Herz J., Selig D.K., Wolff J.R., et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 1995, 375:488-493.
16. Li L., Chin L.S., Shupliakov O., Brodin L., Sihra T.S., Hvalby O., et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice. Proc Natl Acad Sci USA 1995, 92:9235-9239.
17. Ryan T.A., Li L., Chin L.S., Greengard P., Smith S.J. Synaptic vesicle recycling in synapsin I knock-out mice. J Cell Biol 1996, 134:1219-1227.
18. Baldelli P., Fassio A., Valtorta F., Benfenati F. Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci 2007, 27:13520-13531.
19. Gitler D., Takagishi Y., Feng J., Ren Y., Rodriguiz R.M., Wetsel W.C., et al. Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci 2004, 24:11368-11380.
20. Gitler D., Cheng Q., Greengard P., Augustine G.J. Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles. J Neurosci 2008, 28:10835-10843.
21. Kile B.M., Guillot T.S., Venton B.J., Wetsel W.C., Augustine G.J., Wightman R.M. Synapsins differentially control dopamine and serotonin release. J Neurosci 2010, 30:9762-9770.
22. Gaffield M.A., Betz W.J. Synaptic vesicle mobility in mouse motor nerve terminals with and without synapsin. J Neurosci 2007, 27:13691-13700.
23. Pieribone V.A., Porton B., Rendon B., Feng J., Greengard P., Kao H.T. Expression of synapsin III in nerve terminals and neurogenic regions of the adult brain. J Comp Neurol 2002, 454:105-114.
24. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
25. Kao H.T., Li P., Chao H.M., Janoschka S., Pham K., Feng J., et al. Early involvement of synapsin III in neural progenitor cell development in the adult hippocampus. J Comp Neurol 2008, 507:1860-1870.
26. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376.
27. Gould E., McEwen B.S., Tanapat P., Galea L.A., Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997, 17:2492-2498.
28. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 2003, 17:879-886.
29. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
30. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
31. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000, 75:1729-1734.
32. Hanson N.D., Nemeroff C.B., Owens M.J. Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist r121919, increases cell proliferation in the adult dentate gyrus. J Pharmacol Exp Ther 2011, 337:180-186.
33. Wakade C.G., Mahadik S.P., Waller J.L., Chiu F.C. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 2002, 69:72-79.
34. Halim N.D., Weickert C.S., McClintock B.W., Weinberger D.R., Lipska B.K. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 2004, 29:1063-1069.
35. Keilhoff G., Grecksch G., Bernstein H.G., Roskoden T., Becker A. Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci 2010, 260:151-162.
36. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 2004, 56:570-580.
37. Nasrallah H.A., Hopkins T., Pixley S.K. Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain Res 2010, 1354:23-29.
38. Wang H.D., Dunnavant F.D., Jarman T., Deutch A.Y. Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 2004, 29:1230-1238.
39. Banker G.A., Cowan W.M. Rat hippocampal neurons in dispersed cell culture. Brain Res 1977, 126:397-442.
40. Banker G.A., Cowan W.M. Further observations on hippocampal neurons in dispersed cell culture. J Comp Neurol 1979, 187:469-493.
41. Chin L.S., Li L., Ferreira A., Kosik K.S., Greengard P. Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice. Proc Natl Acad Sci USA 1995, 92:9230-9234.
42. Ferreira A., Han H.Q., Greengard P., Kosik K.S. Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture. Proc Natl Acad Sci USA 1995, 92:9225-9229.
43. Feighner JP Mechanism of action of antidepressant medications. J Clin Psychiatry 1999, 60(Suppl 4):4-11. discussion 2-3.
44. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976, 261:717-719.
45. Lieberman J.A., Kinon B.J., Loebel A.D. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990, 16:97-110.
46. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988, 1:179-186.
47. Post R.M., Weiss S.R., Chuang D.M. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol 1992, 12:23S-35S.
48. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
49. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987, 44:660-669.
50. Blumberg H.P., Kaufman J., Martin A., Charney D.S., Krystal J.H., Peterson B.S. Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Ann N Y Acad Sci 2004, 1021:376-383.
51. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., et al. Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010, 68:314-319.
52. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res 1982, 17:319-334.
53. Walker E., Green M. Soft signs of neurological dysfunction in schizophrenia: an investigation of lateral performance. Biol Psychiatry 1982, 17:381-386.
54. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt 4):593-624.
55. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997, 74:129-140.
56. Arnold S.E., Hyman B.T., Van Hoesen G.W., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991, 48:625-632.
57. Rosoklija G., Toomayan G., Ellis S.P., Keilp J., Mann J.J., Latov N., et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000, 57:349-356.
58. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57:65-73.
59. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998, 55:215-224.
60. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991, 17:597-608.
61. Kao H.-T., Porton B. Synaptic Vesicle Associated Proteins and Schizophrenia. Handbook of Neurochemistry and MolecularNeurobiology Schizophrenia 2009, 267-284. Springer, New York. A. Lajtha, D.C. Javitt, J. Kantrowitz (Eds.).
62. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28:53-67.
63. Eisch A.J., Cameron H.A., Encinas J.M., Meltzer L.A., Ming G.L., Overstreet-Wadiche L.S. Adult neurogenesis, mental health, and mental illness: hope or hype?. J Neurosci: Off J Soc Neurosci 2008, 28:11785-11791.
64. Altman J., Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965, 124:319-335.
65. Kaplan M.S., Hinds J.W. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science 1977, 197:1092-1094.
66. Luskin M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993, 11:173-189.
67. Lois C., Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science 1994, 264:1145-1148.
68. Lois C., Garcia-Verdugo J.M., Alvarez-Buylla A. Chain migration of neuronal precursors. Science 1996, 271:978-981.
69. Song H.J., Stevens C.F., Gage F.H. Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat Neurosci 2002, 5:438-445.
70. van Praag H., Schinder A.F., Christie B.R., Toni N., Palmer T.D., Gage F.H. Functional neurogenesis in the adult hippocampus. Nature 2002, 415:1030-1034.
71. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
72. Marazziti D., Consoli G., Picchetti M., Carlini M., Faravelli L. Cognitive impairment in major depression. Eur J Pharmacol 2010, 626:83-86.
73. Osuji I.J., Cullum C.M. Cognition in bipolar disorder. Psychiatr Clin North Am 2005, 28:427-441.
74. MacDonald A.W., Carter C.S. Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift. J Clin Exp Neuropsychol 2002, 24:873-882.
75. Crawley J.N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 1997, 31:197-211.
76. Porton B., Rodriguiz R.M., Phillips L.E., Gilbert J.Wt., Feng J., Greengard P., et al. Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear. Genes Brain Behav 2010, 9:257-268.
77. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
78. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
79. Holmes A., Wrenn C.C., Harris A.P., Thayer K.E., Crawley J.N. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 2002, 1:55-69.
80. Ross R.S., Eichenbaum H. Dynamics of hippocampal and cortical activation during consolidation of a nonspatial memory. J Neurosci: Off J Soc Neurosci 2006, 26:4852-4859.
81. Bunsey M., Eichenbaum H. Critical role of the parahippocampal region for paired-associate learning in rats. Behav Neurosci 1993, 107:740-747.
82. Winocur G., McDonald R.M., Moscovitch M. Anterograde and retrograde amnesia in rats with large hippocampal lesions. Hippocampus 2001, 11:18-26.
83. Logue S.F., Paylor R., Wehner J.M. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav Neurosci 1997, 111:104-113.
84. Tebartz Van Elst L., Baeumer D., Lemieux L., Woermann F.G., Koepp M., Krishnamoorthy S., et al. Amygdala pathology in psychosis of epilepsy: a magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain 2002, 125:140-149.
85. Williams L.M., Das P., Liddell B.J., Olivieri G., Peduto A.S., David A.S., et al. Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res 2007, 155:29-44.
86. Hyman S. Mental illness: genetically complex disorders of neural circuitry and neural communication. Neuron 2000, 28:321-323.
87. Frey B.N., Andreazza A.C., Nery F.G., Martins M.R., Quevedo J., Soares J.C., et al. The role of hippocampus in the pathophysiology of bipolar disorder. Behav Pharmacol 2007, 18:419-430.
88. Ng W.X., Lau I.Y., Graham S., Sim K. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci Biobehav Rev 2009, 33:336-354.
89. Vawter M.P., Thatcher L., Usen N., Hyde T.M., Kleinman J.E., Freed W.J. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:571-578.
90. Volk D.W., Lewis D.A. Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci 2010, 4:485-508.
91. Cerullo M.A., Adler C.M., Delbello M.P., Strakowski S.M. The functional neuroanatomy of bipolar disorder. Int Rev Psychiatry 2009, 21:314-322.
92. Porton B., Wetsel W.C. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia. Schizophr Res 2007, 94:366-370.
93. Albert K.A., Hemmings H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 2002, 59:705-712.
94. Kety S.S., Rosenthal D., Wender P.H., Schulsinger F. Studies based on a total sample of adopted individuals and their relatives: why they were necessary, what they demonstrated and failed to demonstrate. Schizophr Bull 1976, 2:413-428.
95. Abdolmaleky H.M., Thiagalingam S., Wilcox M. Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am J Pharmacogenomics 2005, 5:149-160.
96. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
97. Joober R., Boksa P. A new wave in the genetics of psychiatric disorders: the copy number variant tsunami. J Psychiatry Neurosci 2009, 34:55-59.
98. McClellan J., King M.C. Genomic analysis of mental illness: a changing landscape. JAMA 2010, 303:2523-2524.
99. Gill M., Vallada H., Collier D., Sham P., Holmans P., Murray R., et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12, Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996, 67:40-45.
100. Liu Y.L., Fann C.S., Liu C.M., Chen W.J., Wu J.Y., Hung S.I., et al. RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function. Biol Psychiatry 2008, 64:789-796.
101. Potash J.B., Buervenich S., Cox N.J., Zandi P.P., Akula N., Steele J., et al. Gene-based SNP mapping of a psychotic bipolar affective disorder linkage region on 22q12.3: association with HMG2L1 and TOM1. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:59-67.
102. Kelsoe J.R., Spence M.A., Loetscher E., Foguet M., Sadovnick A.D., Remick R.A., et al. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 2001, 98:585-590.
103. Grover D., Verma R., Goes F.S., Mahon P.L., Gershon E.S., McMahon F.J., et al. Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:977-983.
104. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411.
105. Berrettini W. Bipolar disorder and schizophrenia: convergent molecular data. Neuromolecular Med 2004, 5:109-117.
106. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006, 32:9-16.
107. Wildenauer D.B., Schwab S.G., Maier W., Detera-Wadleigh SD Do schizophrenia and affective disorder share susceptibility genes?. Schizophr Res 1999, 39:107-111. discussion 60.
108. Chen Q., Che R., Wang X., O'Neill F.A., Walsh D., Tang W., et al. Association and expression study of synapsin III and schizophrenia. Neurosci Lett 2009, 465:248-251.
109. Ohmori O., Shinkai T., Hori H., Kojima H., Nakamura J. Synapsin III gene polymorphisms and schizophrenia. Neurosci Lett 2000, 279:125-127.
110. Tsai M.T., Hung C.C., Tsai C.Y., Liu M.Y., Su Y.C., Chen Y.H., et al. Mutation analysis of synapsin III gene in schizophrenia. Am J Med Genet 2002, 114:79-83.
111. Ohtsuki T., Ichiki R., Toru M., Arinami T. Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia. Psychiatry Res 2000, 94:1-7.
112. Stober G., Meyer J., Nanda I., Wienker T.F., Saar K., Knapp M., et al. Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13. Am J Med Genet 2000, 96:392-397.
113. Imai K., Harada S., Kawanishi Y., Tachikawa H., Okubo T., Suzuki T. Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia. Neuropsychobiology 2001, 43:237-241.
114. Lachman H.M., Stopkova P., Rafael M.A., Saito T. Association of schizophrenia in African Americans to polymorphism in synapsin III gene. Psychiatr Genet 2005, 15:127-132.
115. Hall H., Lawyer G., Sillen A., Jonsson E.G., Agartz I., Terenius L., et al. Potential genetic variants in schizophrenia: a Bayesian analysis. World J Biol Psychiatry 2007, 8:12-22.
116. McConnell S.K. Constructing the cerebral cortex: neurogenesis and fate determination. Neuron 1995, 15:761-768.
117. Thompson Ray M., Weickert C.S., Wyatt E., Webster M.J. Decreased BDNF trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci 2011, 36:195-203.
118. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., et al. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 2000, 5:293-300.
119. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001, 52:79-86.
120. Weickert C.S., Ligons D.L., Romanczyk T., Ungaro G., Hyde T.M., Herman M.M., et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2005, 10:637-650.
121. Schramm M., Falkai P., Feldmann N., Knable M.B., Bayer T.A. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci Lett 1998, 257:65-68.
122. Kyosseva S.V. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:997-1006.
123. Lachman H.M., Stopkova P., Papolos D.F., Pedrosa E., Margolis B., Aghalar M.R., et al. Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder. Neuropsychobiology 2006, 53:57-62.
124. Liguori M., Cittadella R., Manna I., Valentino P., La Russa A., Serra P., et al. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis. J Neurol 2004, 251:165-170.
125. Akkad D.A., Godde R., Epplen J.T. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J Neurol 2006, 253:1365-1366.
126. Otaegui D., Zuriarrain O., Castillo-Trivino T., Aransay A., Ruiz-Martinez J., Olaskoaga J., et al. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients. Mult Scler 2009, 15:124-128.
127. Greengard P. The neurobiology of slow synaptic transmission. Science 2001, 294:1024-1030.